Arix to Present at the Proactive One2One Virtual Investor Forum

LONDON, 08 April 2021: Arix Bioscience plc ("Arix", LSE: ARIX), a global venture capital company focused on investing in and building breakthrough biotech companies, announces thatNaseem Amin, Executive Chairman, will present at the Proactive One2One Virtual Investor Forum today, Thursday,8 April 2021 at 7:00pm BST.

Information
Retrieved on: 
Thursday, April 8, 2021 - 8:00am
Geotags: 
Content
Key Points: 
  • LONDON, 08 April 2021: Arix Bioscience plc ("Arix", LSE: ARIX), a global venture capital company focused on investing in and building breakthrough biotech companies, announces thatNaseem Amin, Executive Chairman, will present at the Proactive One2One Virtual Investor Forum today, Thursday,8 April 2021 at 7:00pm BST.
  • Arix will be one of four companies presenting on the evening, each having a presentation slot followed by Q&A, with the webinar taking place from 6.00pm.
  • Investors can register to attend here: https://event.webinarjam.com/register/1024/gwwg2hxq9
    A replay of the presentation will be available after the event, on the investor relations section of the Arix website at https://arixbioscience.com/investor-relations/events-presentations
    For more information on Arix, please contact:



Arix Bioscience PLC


Arix to Present at the Proactive One2One Virtual Investor Forum

08-Apr-2021 / 07:00 GMT/BST


 

Arix Bioscience plc

 

Arix to Present at the Proactive One2One Virtual Investor Forum

 

LONDON, 08 April 2021: Arix Bioscience plc ("Arix", LSE: ARIX), a global venture capital company focused on investing in and building breakthrough biotech companies, announces that Naseem Amin, Executive Chairman, will present at the Proactive One2One Virtual Investor Forum today, Thursday, 8 April 2021 at 7:00pm BST. Arix will be one of four companies presenting on the evening, each having a presentation slot followed by Q&A, with the webinar taking place from 6.00pm.

Investors can register to attend here: https://event.webinarjam.com/register/1024/gwwg2hxq9

A replay of the presentation will be available after the event, on the investor relations section of the Arix website at https://arixbioscience.com/investor-relations/events-presentations

[ENDS]

For more information on Arix, please contact:

 

Arix Bioscience plc

Charlotte Parry, Head of Investor Relations

+44 (0)20 7290 1072

charlotte@arixbioscience.com

 

 

Optimum Strategic Communications

Mary Clark, Supriya Mathur, Shabnam Bashir

+44 (0)20 3922 1906

optimum.arix@optimumcomms.com

 

 

About Arix Bioscience plc

Arix Bioscience plc is a global venture capital company focused on investing in and building breakthrough biotech companies around cutting-edge advances in life sciences.

We collaborate with exceptional entrepreneurs and provide the capital, expertise and global networks to help accelerate their ideas into important new treatments for patients. As a listed company, we are able to bring this exciting growth phase of our industry to a broader range of investors. www.arixbioscience.com

 

 

 




Dissemination of a CORPORATE NEWS, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

1182031  08-Apr-2021 

fncls.ssp?fn=show_t_gif&application_id=1182031&application_name=news&site_id=jotup